Naif Alsuhaymi

Mecca, 21912, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Ertugliflozin ameliorates thioacetamide-induced renal injury by modulating Nrf2-mediated oxidative stress, TLR4/STAT3 inflammatory signaling, and YAP/TAZ fibrotic pathways.

Ertugliflozin ameliorates thioacetamide-induced renal injury by modulating Nrf2-mediated oxidative stress, TLR4/STAT3 inflammatory signaling, and YAP/TAZ fibrotic pathways.

Journal: Toxicology mechanisms and methods

Published: April 18, 2026

Ipragliflozin exerts anti-fibrotic effects via a novel multi-pathway mechanism: Targeting TLR4/NF-κB /TGF-β1 cascade.

Ipragliflozin exerts anti-fibrotic effects via a novel multi-pathway mechanism: Targeting TLR4/NF-κB /TGF-β1 cascade.

Journal: The international journal of biochemistry & cell biology

Published: February 26, 2026

Retraction Note: Protective and therapeutic effects of two novel strains of Lactobacilli on diabetes-associated disorders induced by a high level of fructose.

Retraction Note: Protective and therapeutic effects of two novel strains of Lactobacilli on diabetes-associated disorders induced by a high level of fructose.

Journal: Molecular biology reports

Published: February 21, 2026

Therapeutic potential of canagliflozin in DEN/TAA-induced renal cancer: mechanistic insights into NLRP3/IL-6/STAT3 and AMPK signaling and oxidative stress regulation.

Therapeutic potential of canagliflozin in DEN/TAA-induced renal cancer: mechanistic insights into NLRP3/IL-6/STAT3 and AMPK signaling and oxidative stress regulation.

Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Published: March 25, 2025

Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways.

Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways.

Journal: Frontiers in pharmacology

Published: March 21, 2025

Comprehensive pan-cancer analysis of LAMA3: implications for prognosis and immunotherapy.

Comprehensive pan-cancer analysis of LAMA3: implications for prognosis and immunotherapy.

Journal: American journal of translational research

Published: July 13, 2024

Apigenin: A Bioflavonoid with a Promising Role in Disease Prevention and Treatment.

Apigenin: A Bioflavonoid with a Promising Role in Disease Prevention and Treatment.

Journal: Biomedicines

Published: May 09, 2024

Exploring potential key genes and pathways associatedwith hepatocellular carcinoma prognosis through bioinformatics analysis, followed by experimental validation.

Exploring potential key genes and pathways associatedwith hepatocellular carcinoma prognosis through bioinformatics analysis, followed by experimental validation.

Journal: American journal of translational research

Published: March 28, 2024

Oleuropein, a phenolic component of Olea europaea L. ameliorates CCl4-induced liver injury in rats through the regulation of oxidative stress and inflammation.

Oleuropein, a phenolic component of Olea europaea L. ameliorates CCl4-induced liver injury in rats through the regulation of oxidative stress and inflammation.

Journal: European review for medical and pharmacological sciences

Published: March 04, 2024

Therapeutic Effects of Nigella sativa Oil and Whole Seeds on STZ-Induced Diabetic Rats: A Biochemical and Immunohistochemical Study.

Therapeutic Effects of Nigella sativa Oil and Whole Seeds on STZ-Induced Diabetic Rats: A Biochemical and Immunohistochemical Study.

Journal: Oxidative medicine and cellular longevity

Published: January 31, 2024

Unveiling the unexplored novel signatures for osteoporosis via a detailed bioinformatics and molecular experiments based approach.

Unveiling the unexplored novel signatures for osteoporosis via a detailed bioinformatics and molecular experiments based approach.

Journal: American journal of translational research

Published: December 04, 2023

Comprehensive pan-cancer analysis reveals VSIR as a candidate immunologic, diagnostic, and prognostic biomarker.

Comprehensive pan-cancer analysis reveals VSIR as a candidate immunologic, diagnostic, and prognostic biomarker.

Journal: American journal of translational research

Published: November 03, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026